Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: A Danish case-cohort study

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 10, 2012, Pages 2191-2193

  El Galaly, T C ^a   Kristensen, S R ^a,b   Overvad, K ^b,c   Steffensen, R ^a   Tjonneland A ^d   Severinsen, M T ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b Center for Cardiovascular Research   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; BLOOD GROUP TYPING; BODY MASS; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DENMARK; FEMALE; GENE MUTATION; HUMAN; LETTER; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SMOKING; VENOUS THROMBOEMBOLISM;

ABO BLOOD-GROUP SYSTEM; BLOOD GROUPING AND CROSSMATCHING; DENMARK; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; POINT MUTATION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; VENOUS THROMBOEMBOLISM;

EID: 84866846515     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04772.x     Document Type: Letter

References (10)

1. Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-9.
2. Morelli VM, de Visser MC, Vos HL, Bertina RM, Rosendaal FR. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2005; 3: 183-5.
3. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjønneland A, Overvad K. Smoking and venous thromboembolism: a Danish follow-up study. J Thromb Haemost 2009; 7: 1297-303.
4. Rothman KJ. The estimation of synergy or antagonism. Am J Epidemiol 1976; 103: 506-11.
5. O'Donnell J, Boulton FE, Manning RA, Laffan MA. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335-41.
6. Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD, Folsom AR. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 2007; 5: 1455-61.
7. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 1995; 345: 152-5.
8. Severinsen MT, Kristensen SR, Johnsen SP, Dethlefsen C, Tjonneland A, Overvad K. Anthropometry, body fat, and venous thromboembolism: a Danish follow-up study. Circulation 2009; 120: 1850-7.
9. Wolpin BM, Kabrhel C, Varraso R, Kraft P, Rimm EB, Goldhaber SZ, Camargo CA Jr, Fuchs CS. Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies. Thromb Haemost 2010; 104: 962-71.
10. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007; 131: 1557-66.